Profile
Sector:
HealthcareCountry:
Hong KongIPO:
16 July 2021Next earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 28 Jun 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Regencell Bioscience Holdings Limited?
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
What sector is Regencell Bioscience Holdings Limited in?
Regencell Bioscience Holdings Limited is in the Healthcare sector
What industry is Regencell Bioscience Holdings Limited in?
Regencell Bioscience Holdings Limited is in the Drug Manufacturers - Specialty & Generic industry
What country is Regencell Bioscience Holdings Limited from?
Regencell Bioscience Holdings Limited is headquartered in Hong Kong
When did Regencell Bioscience Holdings Limited go public?
Regencell Bioscience Holdings Limited initial public offering (IPO) was on 16 July 2021
What is Regencell Bioscience Holdings Limited website?
https://www.regencellbioscience.com
Is Regencell Bioscience Holdings Limited in the S&P 500?
No, Regencell Bioscience Holdings Limited is not included in the S&P 500 index
Is Regencell Bioscience Holdings Limited in the NASDAQ 100?
No, Regencell Bioscience Holdings Limited is not included in the NASDAQ 100 index
Is Regencell Bioscience Holdings Limited in the Dow Jones?
No, Regencell Bioscience Holdings Limited is not included in the Dow Jones index
When does Regencell Bioscience Holdings Limited report earnings?
Next earnings report date is not announced yet